Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | APL-5125 |
| Synonyms | |
| Therapy Description |
APL-5125 is a small molecule inhibitor of Wnt signaling that inhibits an undisclosed kinase in the Wnt pathway, potentially resulting in decreased tumor cell growth (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| APL-5125 | APL 5125|APL5125 | WNT Inhibitor 17 | APL-5125 is a small molecule inhibitor of Wnt signaling that inhibits an undisclosed kinase in the Wnt pathway, potentially resulting in decreased tumor cell growth (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06399757 | Phase Ib/II | APL-5125 | A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors | Recruiting | USA | 0 |